NCT04171141: Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. |
|
|
| Terminated | 1 | 79 | Japan, US, RoW | PF-07062119, Anti-PD1, Anti-VEGF | Pfizer | Gastrointestinal Tumors, Colorectal Adenocarcinomas, Gastric Adenocarcinomas, Esophageal Adenocarcinomas | 11/23 | 11/23 | | |
